Clincosm LogoSign in Get a demo

peripheral t cell lymphoma

Showing 1 - 25 of 35
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Cancer, Follicular Lymphoma, Peripheral T Cell Lymphoma Trial (BR1733)

Not yet recruiting
  • Advanced Cancer
  • +3 more
  • (no location specified)
Feb 27, 2023

Peripheral T Cell Lymphoma Trial (CHOP+selinexor+5-Azacitidine, CHOP+duvelisib+5-Azacitidine, CHOP+chidamide+tislelizumab)

Not yet recruiting
  • Peripheral T Cell Lymphoma
  • (no location specified)
Dec 29, 2022

Peripheral T Cell Lymphoma Trial in Shanghai (Azacitidine Injection, Dasatinib, Linperlisib)

Recruiting
  • Peripheral T Cell Lymphoma
  • Azacitidine Injection
  • +6 more
  • Shanghai, Shanghai, China
    Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
Nov 8, 2022

Peripheral T Cell Lymphoma Trial in Houston (Tenalisib)

Not yet recruiting
  • Peripheral T Cell Lymphoma
  • Houston, Texas
    The University of Texas MD Anderson Cancer Center
Aug 17, 2022

Peripheral T Cell Lymphoma Trial in Zhejiang (Mitoxantrone liposome?Chidamide?Azacitidine)

Recruiting
  • Peripheral T Cell Lymphoma
  • Mitoxantrone liposome、Chidamide、Azacitidine
  • Zhejiang, Zhejiang, China
    Second Affiliated Hospital, School of Medicine, Zhejiang Univers
Aug 9, 2022

Peripheral T Cell Lymphoma Trial in France (Chemotherapy + follow up, Chemotherapy + ASCT + follow up)

Recruiting
  • Peripheral T Cell Lymphoma
  • Chemotherapy + follow up
  • Chemotherapy + ASCT + follow up
  • Amiens, France
  • +47 more
Aug 2, 2022

Anaplastic Large Cell Lymphoma, Peripheral T Cell Lymphoma, Extranodal NK/T-cell Lymphoma Trial in Duarte, Nashville, Houston

Active, not recruiting
  • Anaplastic Large Cell Lymphoma
  • +4 more
  • Duarte, California
  • +3 more
Jul 21, 2022

T-Cell Non-Hodgkin Lymphoma, Acute Myeloid Leukemia, Angioimmunoblastic T-cell Lymphoma Trial in Saint Louis (WU-CART-007)

Not yet recruiting
  • T-Cell Non-Hodgkin Lymphoma
  • +14 more
  • WU-CART-007
  • Saint Louis, Missouri
    Washington University School of Medicine
May 11, 2022

T Lymphoblastic Leukemia/Lymphoma, T-cell Acute Lymphoblastic Leukemia, Peripheral T Cell Lymphoma Trial in Shanghai (anti-CD7

Recruiting
  • T Lymphoblastic Leukemia/Lymphoma
  • +4 more
  • anti-CD7 CAR-T cells
  • Shanghai, China
    Xianmin General Song
May 3, 2022

Peripheral T Cell Lymphoma Trial in Korea, Republic of, United States (lacutamab)

Recruiting
  • Peripheral T Cell Lymphoma
  • lacutamab
  • Birmingham, Alabama
  • +18 more
Apr 4, 2022

Peripheral T Cell Lymphoma Trial in Chapel Hill, Winston-Salem (ATLCAR.CD30 T cells, Bendamustine, Fludarabine)

Recruiting
  • Peripheral T Cell Lymphoma
  • ATLCAR.CD30 T cells
  • +3 more
  • Chapel Hill, North Carolina
  • +1 more
Mar 4, 2022

Minimal Residual Disease in Peripheral T-cell Lymphoma

Active, not recruiting
  • Peripheral T Cell Lymphoma
  • Tumor biopsy
  • +2 more
  • Boston, Massachusetts
  • +2 more
Feb 14, 2022

Lymphoma, Large B-Cell, Diffuse, Mantle Cell Lymphoma, Peripheral T Cell Lymphoma Trial in Nanjing (Chidamide)

Active, not recruiting
  • Lymphoma, Large B-Cell, Diffuse
  • +3 more
  • Nanjing, Jiangsu, China
    Hematological Department, People's Hospital of Jiangsu Province
Dec 30, 2021

Peripheral T Cell Lymphoma, Relapse/Recurrence Trial in Belgium, France (Lacutamab, Gemcitabine, Oxaliplatine)

Recruiting
  • Peripheral T Cell Lymphoma
  • Relapse/Recurrence
  • Antwerpen, Belgium
  • +38 more
Dec 6, 2021

Brentuximab Vedotin Intravenous Infusion "Relapsed or Refractory

Active, not recruiting
  • Peripheral T Cell Lymphoma
  • Pediatric Hodgkin Lymphoma
  • Brentuximab Vedotin (Genetical Recombination)
  • Tokyo, Japan
    Takeda Selected Site
Sep 29, 2021

Peripheral T Cell Lymphoma Trial in Ann Arbor, Columbus, Madison (Nivolumab, cabiralizumab)

Active, not recruiting
Has Results
  • Peripheral T Cell Lymphoma
  • Ann Arbor, Michigan
  • +2 more
Aug 13, 2021

NK-Cell Lymphoma, NK-Cell Leukemia, Peripheral T Cell Lymphoma Trial in San Francisco, Valhalla (Methotrexate, pralatraxate,,

Recruiting
  • NK-Cell Lymphoma
  • +2 more
  • San Francisco, California
  • +1 more
Sep 1, 2021

Treatment-naïve, Peripheral T Cell Lymphoma Trial in Guangzhou (Dose-finding stage: Liposomal mitoxantrone HCl,

Recruiting
  • Treatment-naïve
  • Peripheral T Cell Lymphoma
  • Dose-finding stage: Liposomal mitoxantrone hydrochloride, Cyclophosphamide, Vincristine and Prednisone
  • Dose-expansion stage: Liposomal mitoxantrone hydrochloride, Cyclophosphamide, Vincristine and Prednisone
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Jul 26, 2021

Peripheral T Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Anaplastic Lymphoma Trial in Shanghai (anti-TRBC1 CAR-T cell

Recruiting
  • Peripheral T Cell Lymphoma
  • +4 more
  • anti-TRBC1 CAR-T cell therapy
  • Shanghai, Shanghai, China
    Xianmin Song
Mar 31, 2021

Peripheral T Cell Lymphoma Trial in Beijing (GB226)

Recruiting
  • Peripheral T Cell Lymphoma
  • GB226
  • Beijing, Beijing, China
    Cancer Hospital Chinese Academy of Medical Sciences
Mar 2, 2021

Peripheral T Cell Lymphoma Trial in Guangzhou (Mitoxantrone Hydrochloride Liposome Injection, Chidamide)

Not yet recruiting
  • Peripheral T Cell Lymphoma
  • Mitoxantrone Hydrochloride Liposome Injection
  • Chidamide
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Dec 11, 2020

Peripheral T Cell Lymphoma Trial (F520)

Not yet recruiting
  • Peripheral T Cell Lymphoma
  • (no location specified)
Oct 19, 2020

Peripheral T Cell Lymphoma Trial in Canton (PLM60)

Withdrawn
  • Peripheral T Cell Lymphoma
  • Canton, Ohio
  • +1 more
Oct 14, 2020

Peripheral T Cell Lymphoma Trial in Hangzhou (Bortezomib, Etoposide, Cyclophosphamide)

Unknown status
  • Peripheral T Cell Lymphoma
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Aug 18, 2019

Adult T-Cell Lymphoma/Leukaemia, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in Wuhan (Anti-CD30

Recruiting
  • Adult T-Cell Lymphoma/Leukaemia
  • +5 more
  • Anti-CD30 CAR T cells
  • Wuhan, Hubei, China
    Union Hospital, Tongji Medical College, Huazhong University of S
Aug 5, 2019